E Fund Management Co., Ltd. Alaunos Therapeutics, Inc. Transaction History

E Fund Management Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.04 - $322.5 $15,773 - $4.89 Million	15,167 New	15,167 $26,000
Q1 2022 May 12, 2022	SELL	$0.62 - $1.17 $16,723 - $31,558	-26,973 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.09 - $1.89 $4,675 - $8,106	4,289 Added 18.91%	26,973 $29,000
Q3 2021 Nov 12, 2021	BUY	$1.44 - $2.73 $371 - $704	258 Added 1.15%	22,684 $41,000
Q1 2021 May 12, 2021	BUY	$2.82 - $5.6 $63,241 - $125,585	22,426 New	22,426 $80,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.